Carl Byrnes
Stock Analyst at Northland Capital Markets
(0.79)
# 2,910
Out of 4,479 analysts
14
Total ratings
44.44%
Success rate
-5.88%
Average return
Main Sectors:
9 Stocks
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
COCH Envoy Medical | Initiates: Outperform | n/a | $2.21 | - | 1 | Dec 21, 2023 | |
AMRN Amarin Corporation | Maintains: Market Perform | $2 → $1.25 | $0.71 | +77.30% | 1 | Jul 19, 2023 | |
CDIO Cardio Diagnostics Holdings | Initiates: Outperform | $8 | $0.54 | +1,380.11% | 1 | May 22, 2023 | |
BWAY BrainsWay | Maintains: Outperform | $15 → $5 | $5.92 | -15.54% | 1 | Nov 17, 2022 | |
VTVT vTv Therapeutics | Maintains: Outperform | $60 → $80 | $18.28 | +337.64% | 3 | Aug 17, 2022 | |
MDXG MiMedx Group | Initiates: Outperform | n/a | $6.78 | - | 1 | Jul 26, 2021 | |
ESPR Esperion Therapeutics | Maintains: Market Perform | n/a | $2.34 | - | 4 | May 5, 2021 | |
AYTU Aytu BioPharma | Initiates: Outperform | n/a | $2.86 | - | 1 | Oct 22, 2018 | |
HRTX Heron Therapeutics | Initiates: Outperform | n/a | $2.74 | - | 1 | Sep 27, 2017 |
Envoy Medical
Dec 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $2.21
Upside: -
Amarin Corporation
Jul 19, 2023
Maintains: Market Perform
Price Target: $2 → $1.25
Current: $0.71
Upside: +77.30%
Cardio Diagnostics Holdings
May 22, 2023
Initiates: Outperform
Price Target: $8
Current: $0.54
Upside: +1,380.11%
BrainsWay
Nov 17, 2022
Maintains: Outperform
Price Target: $15 → $5
Current: $5.92
Upside: -15.54%
vTv Therapeutics
Aug 17, 2022
Maintains: Outperform
Price Target: $60 → $80
Current: $18.28
Upside: +337.64%
MiMedx Group
Jul 26, 2021
Initiates: Outperform
Price Target: n/a
Current: $6.78
Upside: -
Esperion Therapeutics
May 5, 2021
Maintains: Market Perform
Price Target: n/a
Current: $2.34
Upside: -
Aytu BioPharma
Oct 22, 2018
Initiates: Outperform
Price Target: n/a
Current: $2.86
Upside: -
Heron Therapeutics
Sep 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $2.74
Upside: -